Avacta Group (FRA:RTQ1) Construction In Progress : €0.00 Mil (As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Avacta Group Construction In Progress?

Avacta Group's quarterly construction in progress increased from Jun. 2023 (€0.00 Mil) to Dec. 2023 (€0.39 Mil) but then declined from Dec. 2023 (€0.39 Mil) to Jun. 2024 (€0.00 Mil).

Avacta Group's annual construction in progress declined from Dec. 2021 (€0.17 Mil) to Dec. 2022 (€0.00 Mil) but then increased from Dec. 2022 (€0.00 Mil) to Dec. 2023 (€0.39 Mil).

Avacta Group Construction In Progress Historical Data

The historical data trend for Avacta Group's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avacta Group Construction In Progress Chart

Avacta Group Annual Data

Trend

Jul13

Jul14

Jul15

Jul16

Jul17

Jul18

Dec20

Dec21

Dec22

Dec23

Construction In Progress

Get a 7-Day Free Trial

0.33

0.17

0.39

Avacta Group Semi-Annual Data
	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jan17	Jul17	Jan18	Jul18	Jan19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Construction In Progress	Get a 7-Day Free Trial															-	-	-	0.39	-

Avacta Group Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Avacta Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avacta Group PLC (FRA:RTQ1) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

AVCTF:USA AVCT:UK RTQ1:Germany

Address

Unit 20, Ash Way, Thorp Arch Estate, West Yorkshire, Wetherby, GBR, LS23 7FA

Website

https://www.avacta.com

Avacta Group PLC is a United Kingdom-based biotechnology company. The company offers its products through three segments that are Diagnostics, Therapeutics, and Animal Health. The company is developing novel cancer immunotherapies combining its two proprietary platforms Affimer biotherapeutics and precision tumor-targeted chemotherapy. The company operates in the United Kingdom, France, South Korea, Rest of Europe, Asia, and North America.

Avacta Group Headlines

No Headlines